CEL-SCI Corporation, established in 1983, is a biotechnology company focused on the research and development of innovative immunotherapy treatments for cancer, autoimmune disorders, and infectious diseases. The company’s core competencies include drug discovery, advanced research, product development, and the manufacturing of complex biological compounds.
Summit acted as the General Contractor, managing all aspects of the project with full oversight and ensuring smooth coordination and execution throughout every phase—from initial planning to final completion.
Elkridge, MD 17,670 sqft.